LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Gene Therapy Juventas Therapeutics specializes in developing novel non-viral gene therapies aimed at activating natural tissue repair processes, positioning the company at the forefront of regenerative medicine innovations.

Strong Financial Backing The company secured $14 million in funding and additional financing rounds, indicating investor confidence and providing a potential channel for future funding needs or partnership opportunities.

Clinical Progress Currently engaged in enrolling a Phase 2b trial for peripheral artery disease, Juventas presents opportunities for collaboration in clinical development, supply chain management, and diagnostic solutions.

Strategic Industry Position Juventas operates within the biotech segment with close ties to leading medical research institutions, making it a strategic partner for organizations focused on cardiovascular and regenerative therapies.

Technology and Infrastructure Utilizing cloud-based technologies such as AWS and Cloudflare, Juventas demonstrates a modern IT infrastructure that supports scalable data management, which could open avenues for tech collaboration or software solutions.

Juventas Therapeutics, Inc. Tech Stack

Juventas Therapeutics, Inc. uses 8 technology products and services including Amazon Web Services, Cloudflare CDN, Cloudflare, and more. Explore Juventas Therapeutics, Inc.'s tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Cloudflare CDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • React
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • HTTP/3
    Web & Portal Technology
  • Apache
    Web Servers

Media & News

Juventas Therapeutics, Inc.'s Email Address Formats

Juventas Therapeutics, Inc. uses at least 1 format(s):
Juventas Therapeutics, Inc. Email FormatsExamplePercentage
FLast@juventasinc.comJDoe@juventasinc.com
44%
First@juventasinc.comJohn@juventasinc.com
6%
FLast@juventasinc.comJDoe@juventasinc.com
44%
First@juventasinc.comJohn@juventasinc.com
6%

Frequently Asked Questions

Where is Juventas Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconJuventas Therapeutics, Inc.'s main headquarters is located at 3615 Superior Avenue, Suite 4403b. The company has employees across 2 continents, including North AmericaEurope.

What is Juventas Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Juventas Therapeutics, Inc.'s main corporate office by phone at
+1-216-678-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Juventas Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconJuventas Therapeutics, Inc.'s official website is juventasinc.com and has social profiles on LinkedIn.

What is Juventas Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconJuventas Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Juventas Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of December 2025, Juventas Therapeutics, Inc. has approximately 5 employees across 2 continents, including North AmericaEurope. Key team members include Director Product Development: S. C.. Explore Juventas Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Juventas Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconJuventas Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Juventas Therapeutics, Inc. use?

Minus sign iconPlus sign iconJuventas Therapeutics, Inc.'s tech stack includes Amazon Web ServicesCloudflare CDNCloudflareReactjQueryBootstrapHTTP/3Apache.

What is Juventas Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconJuventas Therapeutics, Inc.'s email format typically follows the pattern of FLast@juventasinc.com. Find more Juventas Therapeutics, Inc. email formats with LeadIQ.

How much funding has Juventas Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of December 2025, Juventas Therapeutics, Inc. has raised $14M in funding. The last funding round occurred on May 12, 2015 for $14M.

When was Juventas Therapeutics, Inc. founded?

Minus sign iconPlus sign iconJuventas Therapeutics, Inc. was founded in 2007.

Juventas Therapeutics, Inc.

Biotechnology ResearchOhio, United States2-10 Employees

Juventas Therapeutics is a private, clinical stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body. Our product candidate, JVS-100, is a non-viral gene therapy that expresses stromal cell-derived factor-1, or SDF-1, a naturally occurring signaling protein that has been shown to recruit the body’s own stem cells and promote tissue repair in a broad range of disease states. Juventas’ therapeutic approach is based on research originating at the Cleveland Clinic. Juventas is currently enrolling a Phase 2b study in patients with advanced peripheral artery disease.

Section iconCompany Overview

Headquarters
3615 Superior Avenue, Suite 4403b
Phone number
+1-216-678-****
Website
juventasinc.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $14M

    Juventas Therapeutics, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on May 12, 2015 in the amount of $14M.

  • $1M

    Juventas Therapeutics, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $14M

    Juventas Therapeutics, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on May 12, 2015 in the amount of $14M.

  • $1M

    Juventas Therapeutics, Inc.'s revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    S. C.
    Director Product Development
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.